OR17-02 Changes in Hepatokines and Apolipoproteins Are Associated with Metabolic Response to Metreleptin in Partial Lipodystrophy

Introduction Metreleptin treatment may improve the metabolic aspects of partial lipodystrophy; however, the treatment response is heterogeneous. This study aimed to explore changes in circulating apolipoprotein concentrations, as well as ANGPLT3, ANGPLT4, and IGF-1 levels in patients treated with Me...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Endocr Soc
Hlavní autoři: Akinci, Baris, Ajluni, Nevin, Eldin, Abdelwahab Jalal, Swaidan, Mario, Hench, Rita, Neidert, Adam, Luo, Yingying, de Freitas, Maria Cristina Foss, Oral, Elif A
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2020
Témata:
Cardiovascular Endocrinology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7207763/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.1104
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky